734 related articles for article (PubMed ID: 17244950)
1. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
Pfaar O; Klimek L
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
[TBL] [Abstract][Full Text] [Related]
2. Aspirin intolerance: does desensitization alter the course of the disease?
Klimek L; Pfaar O
Immunol Allergy Clin North Am; 2009 Nov; 29(4):669-75. PubMed ID: 19879442
[TBL] [Abstract][Full Text] [Related]
3. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements.
Pfaar O; Klimek L
Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):161-6. PubMed ID: 16670507
[TBL] [Abstract][Full Text] [Related]
4. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day].
Gosepath J; Schäfer D; Mann WJ
Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524
[TBL] [Abstract][Full Text] [Related]
5. [Analgesic intolerance: pathogenesis, diagnosis and treatment].
Reiss G; Reiss M
Med Monatsschr Pharm; 2009 Dec; 32(12):445-50; quiz 451-2. PubMed ID: 20088346
[TBL] [Abstract][Full Text] [Related]
6. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG; Simon HU; Schmitz-Schumann M
Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
[TBL] [Abstract][Full Text] [Related]
7. [New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences].
de Weck A; Sanz ML; Gamboa P
Bull Acad Natl Med; 2005 Jun; 189(6):1201-18; discussion 1218-20. PubMed ID: 16433444
[TBL] [Abstract][Full Text] [Related]
8. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients.
Kowalski ML; Pawliczak R; Wozniak J; Siuda K; Poniatowska M; Iwaszkiewicz J; Kornatowski T; Kaliner MA
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):391-8. PubMed ID: 10673176
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to nonsteroidal anti-inflammatory drugs.
Namazy JA; Simon RA
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):542-50; quiz 550, 605. PubMed ID: 12487218
[TBL] [Abstract][Full Text] [Related]
10. [Provocation tests in the diagnosis of acetylsalicylic acid intolerance].
Semik A; Barczyk A; Pierzchała W
Wiad Lek; 2005; 58(9-10):543-8. PubMed ID: 16529067
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release.
Kowalski ML; Borowiec M; Kurowski M; Pawliczak R
Allergy; 2007 Jun; 62(6):628-34. PubMed ID: 17508966
[TBL] [Abstract][Full Text] [Related]
12. [Asthma and aspirin].
Schiappoli M; Gani F; Frati F; Marcucci F; Senna G
Recenti Prog Med; 2003 Feb; 94(2):79-87. PubMed ID: 12908375
[TBL] [Abstract][Full Text] [Related]
13. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
[TBL] [Abstract][Full Text] [Related]
14. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Berges-Gimeno MP; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
[TBL] [Abstract][Full Text] [Related]
15. [Allergy and intolerance to nonsteroidal antinflammatory drugs: successful desensitization in three cases].
Cardona R; Ramírez RH; Reina Z; Escobar MF; Morales E
Biomedica; 2009 Jun; 29(2):181-90. PubMed ID: 20128343
[TBL] [Abstract][Full Text] [Related]
16. [Nasal polyps is not a homogenous pathology].
Arcimowicz M; Balcerzak J; Samoliński BK
Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis, diagnosis, and treatment of aspirin intolerance.
Jenneck C; Juergens U; Buecheler M; Novak N
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):13-21. PubMed ID: 17650824
[TBL] [Abstract][Full Text] [Related]
18. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
[TBL] [Abstract][Full Text] [Related]
19. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
20. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
